The decision in Wuhan Healthgen involved Ventria Bioscience, Inc. (Ventria), a company uniquely tied to the use of animal-friendly alternatives in cell culture media. Despite providing the necessary ...
Ventria Bioscience said today it has won a $4.2 million grant from the Bill & Melinda Gates Foundation toward the biomanufacturing of new therapeutics targeting enterotoxigenic Escherichia coli (ETEC) ...
The biopharmaceutical company has received a $4.2-million grant from the Bill & Melinda Gates Foundation to invest in the development of new treatments for Enterotoxigenic Escherichia coli infections, ...
JUNCTION CITY, Kan.--(BUSINESS WIRE)--Ventria Bioscience Inc. (Ventria) today announced that the United States International Trade Commission (ITC) completed its review of Administrative Law Judge ...
FORT COLLINS, Colo. – March 21, 2012 – Ventria Bioscience today announced an exclusive collaboration with EMD Millipore, the Life Science division of Merck KGaA of Germany, in which Ventria will ...
FORT COLLINS, Colo.--(BUSINESS WIRE)--Ventria Bioscience announces the completion of an agreement under which Ventria Bioscience will wholly acquire portions of the intellectual property portfolio ...
The biopharmaceutical company broke ground on what will be a new 3000-ft2 addition to its Kansas biomanufacturing facility. On Sep. 6, 2017, Ventria Bioscience, a biopharmaceutical company focused on ...
Ventria Bioscience has scored a supply deal with Merck KGaA. The Fort Collins, CO-based Ventria says it struck a contract to supply a recombinant protein for the life sciences arm of Merck KGaA. And ...
The U.S. Department of Agriculture denied Ventria BioScience's request to plant a genetically modified rice crop containing pharmaceuticals, a setback for the California biotech company that had won ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results